Zhongnan Medical Journal Press

Home Results

A total of 54 result was found. Results that relate to Safety

Clinical efficacy and safety evaluation observation of vitamin D combined with atomoxetine hydrochloride in the treatment of attention deficit hyperactivity disorder in children

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):287-294.
1109 times 460 times

QIN Yunfeng LING Yinjie LANG Yan

Vitamin D Atomoxetine hydrochloride Attention deficit hyperactivity disorder Clinical efficacy Safety
Details
Clinical efficacy and safety evaluation of probiotic-assisted chemotherapy in patients with advanced colorectal cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(2):295-301.
903 times 467 times

YE Fan LI Zhuo HUANG Xing XIAO Zhigang

Advanced colorectal cancer Chemotherapy Probiotics Clinical efficacy Safety
Details
Evaluation of the efficacy and safety of Xuefu Zhuyu oral liquid on patients with lupus nephritis and the effect of serum thymosin β4

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):455-462.
1012 times 402 times

XU Na HAN Mei FENG Jinhui SUN Yao REN Zhanfen YANG Yue

Xuefu Zhuyu oral liquid Lupus nephritis Clinical efficacy Safety thymosin β4
Details
Clinical efficacy observation of batroxobin combined with ginaton injection solution in the treatment of patients with sudden deafness and dizziness

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):470-476.
1235 times 499 times

YAN Juan TUO Mingxiang WANG Hong TIAN Qing YANG Hongli AN Li SHI Hao

Sudden deafness Ginaton injection solution Batroxase Inflammatory factors Safety
Details
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma

Published on Frontiers in Pharmaceutical Sciences 2024,27(3):485-490.
970 times 662 times

SU Zhan CHE Jinhui PEI Ruifeng

Advanced hepatocellular carcinoma Sintilimab Bevacizumab Clinical efficacy Safety Overall survival Progression-free survival
Details
Investigation and analysis on the current status of power PICC imaging examination quality

Published on New Medicine 2024,34(4):391-398.
1804 times 2099 times

ZHAO Haiyan HUANG Fen WANG Zhusha WANG Xin LI Hongjun

Power PICC Imaging examination Nursing quality Safety management
Details
Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):519-538.
1431 times 451 times

YU Tian LIU Shaohua WEI Anhua GUO Jieru ZHANG Chengliang LIU Dong LIU Zhelong

Glucagon-like peptide 1 receptor agonists Type 2 diabetes mellitus Obesity or overweight Efficacy Safety Meta-analysis Randomized controlled trial
Details
Efficacy and safety of trastuzumab deruxtecan in the treatment of breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(5):539-548.
1222 times 598 times

ZHANG Xiaoqing LIU Shuai ZHANG Kai LUAN Wei

Trastuzumab deruxtecan Antibody drug conjugates Breast cancer Efficacy Safety Meta-analysis Randomized controlled trial
Details
Evaluation of the efficacy of Huoxue Tongluo recipe iontophoresis combined with butyphthalide sequential therapy in hemiplegia patients with cerebral ischemic stroke

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):788-795.
974 times 459 times

ZHANG Hongli LI Peng HU Jie [LV

Traditional Chinese medicine iontophoresis Butyphthalide sequential therapy Cerebral ischemic stroke Hemiplegia Clinical efficacy Safety
Details
Efficacy and safety of white-browed snake venom hemocoagulase for injection in surgical tresis vulnus: a Meta-analysis

Published on Frontiers in Pharmaceutical Sciences 2024,27(5):864-874.
1100 times 377 times

SHAO Qianhang LIU Xuemei HUANG Lin FENG Yufei

White-browed snake venom hemocoagulase Surgical incision Thrombin time Activated partial thromboplastin time Prothrombin time Fibrinogen Safety Meta-analysis
Details
CiteSpace bibliometric analysis of safety and risk studies of antibody drugs in China

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1019-1027.
1032 times 280 times

PENG Yue LIU Lingling CAI Yuanxuan ZHAO Yuhang SHANGGUAN Xiaofang LI Kangling CHEN Zherui LI Ke HUANG Rui LU Yuanyuan

Antibody drugs CiteSpace Safety Risk Adverse reactions Bibliometrics Drug safety Risk management
Details
Comparison of the effectiveness and safety of semaglutide versus dulaglutide for treating type 2 diabetes: a retrospective cohort study utilizing propensity score matching

Published on Chinese Journal of Pharmacoepidemiology 2024,33(6):601-611.
1562 times 477 times

HE Lanzhi ZHOU Pengxiang HUANG Shulin LIN Chunyan LUO Haikun QI Jianying ZHANG Hongliang CHEN Xiaoyu ZHOU Ganping

Type 2 diabetes Semaglutide Dulaglutide Effectiveness Safety Propensity score matching Generalized estimation equation
Details
A real-world study of the efficacy and safety of linezolid versus vancomycin in the treatment of Enterococcal bloodstream infections

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):770-777.
1289 times 278 times

TANG Bingying YI Maoli GAO Ting HUO Xuechen

Bloodstream infection Enterococci Linezolid Vancomycin Efficacy Safety Propensity score matched
Details
A multicenter, open-label and phase Ⅳ clinical study on the treatment of urinary tract infections with Relinqing granules

Published on New Medicine 2024,34(7):786-795.
2631 times 1367 times

WANG Shusheng ZHANG Junhua YU Lei TANG Huilong SONG Xu YE Chunhua

Relinqing granules Urinary tract infection Phase IV clinical trial Clinical efficacy Safety
Details
Efficacy and safety associated with the infusion speed of immunoglobulin for the treatment of Kawasaki disease

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1149-1154.
1067 times 230 times

ZHA Xuan XU Zhoumei

Infusion speed Kawasaki disease Efficacy Safety Immunoglobulin Coronary artery lesion
Details